Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruyue Liu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Oncology|August 15, 2022
Preference for endoscopic screening of upper gastrointestinal cancer among Chinese rural residents: a discrete choice experimentRuyue Liu, Youhua Lu, Yifan Li, et al.
Nucleic Acids Research|October 3, 2022
microbioTA: an atlas of the microbiome in multiple disease tissues of Homo sapiens and Mus musculusPing Wang, Sainan Zhang, Guoyou He, et al.
Materials Today. Bio|September 8, 2025
Oral targeting tilianin nanoplatform mitigates atherosclerosis through promoting macrophage phagocytosis and anti-inflammationMin Sun, Mengran Guo, Zhongshan He, et al.
Biomaterials|December 24, 2025
A shear-responsive nanosystem engineered from fucoidan targets endothelial for atherosclerosis therapyRuyue Liu, Xuli Ruan, Mengran Guo, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapyYupei Zhang, Shugang Qin, Tingting Song, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Oncology|August 15, 2022
Preference for endoscopic screening of upper gastrointestinal cancer among Chinese rural residents: a discrete choice experimentRuyue Liu, Youhua Lu, Yifan Li, et al.
Nucleic Acids Research|October 3, 2022
microbioTA: an atlas of the microbiome in multiple disease tissues of Homo sapiens and Mus musculusPing Wang, Sainan Zhang, Guoyou He, et al.
Materials Today. Bio|September 8, 2025
Oral targeting tilianin nanoplatform mitigates atherosclerosis through promoting macrophage phagocytosis and anti-inflammationMin Sun, Mengran Guo, Zhongshan He, et al.
Biomaterials|December 24, 2025
A shear-responsive nanosystem engineered from fucoidan targets endothelial for atherosclerosis therapyRuyue Liu, Xuli Ruan, Mengran Guo, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapyYupei Zhang, Shugang Qin, Tingting Song, et al.
Pageof 2